Our study, for the first time, reveals the role of TUBB in CRC progression by combining bioinformatics with clinical sample analysis, emphasizing its potential as a significant risk factor and we also validated its proliferation, anti-apoptosis, and metastasis ability. This evidence concerns the gene TUBB and colorectal carcinoma.